DNVYX
Price
$28.21
Change
+$0.15 (+0.53%)
Updated
Jul 3 closing price
Net Assets
6.75B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DNVYX vs VVIAX

Header iconDNVYX vs VVIAX Comparison
Open Charts DNVYX vs VVIAXBanner chart's image
Davis NY Venture Y
Price$28.21
Change+$0.15 (+0.53%)
VolumeN/A
Net Assets6.75B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DNVYX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNVYX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNVYX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. DNVYX (6.75B). VVIAX pays higher dividends than DNVYX: VVIAX (2.18) vs DNVYX (1.72). DNVYX was incepted earlier than VVIAX: DNVYX (29 years) vs VVIAX (25 years). DNVYX (0.67) is less costly to investors than VVIAX (0.05). DNVYX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than DNVYX: VVIAX (3000) vs DNVYX (5000000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. DNVYX (-2.02). VVIAX return over 5 years is better than : 80.13 vs. DNVYX (11.94).
DNVYXVVIAXDNVYX / VVIAX
Total Expense Ratio0.670.051,340%
Annual Report Gross Expense Ratio0.670.051,340%
Fund Existence29 years25 years-
Gain YTD5.4626.19888%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets6.75B189B4%
Annual Yield % from dividends1.722.1879%
Returns for 1 year-2.0212.03-17%
Returns for 3 years29.1735.1783%
Returns for 5 years11.9480.1315%
Returns for 10 years-10.25115.67-9%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.